Unilever (NYSE: UL) may be a consumer products behemoth with its brands sold across the globe, but its stock is unloved today. The shares are down 23% from their 2020 highs and trading at around the same level as about five years ago.

However, some promising changes are afoot at the U.K.-based company -- and if recent results are any indication, the stock could see a turnaround.

Unilever has been a company in transition. That includes shifting from an odd dual listing structure to just a single listing in the United Kingdom, an effort that was completed in late 2020. Meanwhile, in 2019 the company's leadership passed to a new CEO. And the company is dealing with a dissident shareholder that is now on the board of directors, Nelson Peltz. That last move was hastened by Unilever's failed attempt to acquire the over-the-counter healthcare business of GlaxoSmithKline. And those are just the highlights.

Continue reading

Source Fool.com